Determination of Prenatal Substance Exposure Using Meconium and Orbitrap Mass Spectrometry.

drug of abuse mass spectrometry meconium newborn orbitrap toxicology

Journal

Toxics
ISSN: 2305-6304
Titre abrégé: Toxics
Pays: Switzerland
ID NLM: 101639637

Informations de publication

Date de publication:
26 Jan 2022
Historique:
received: 23 12 2021
revised: 21 01 2022
accepted: 22 01 2022
entrez: 24 2 2022
pubmed: 25 2 2022
medline: 25 2 2022
Statut: epublish

Résumé

The aim of this study was to develop and to validate a toxicological untargeted screening relying on LC-HRMS in meconium including the detection of the four main classes of drugs of abuse (DoA; amphetamines, cannabinoids, opioids and cocaine). The method was then applied to 29 real samples. Analyses were performed with a liquid chromatography system coupled to a benchtop Orbitrap operating in a data-dependent analysis. The sample amount was 300 mg of meconium extracted twice by solid phase extraction following two distinct procedures. Raw data were processed using the Compound Discoverer 3.2 software (Thermo). The method was evaluated and validated on 15 compounds (6-MAM, morphine, buprenorphine, norbuprenorphine, methadone, EDDP, amphetamine, MDA, MDMA, methamphetamine, cocaine, benzoylecgonine, THC, 11-OH-THC, THC-COOH). Limits of detection were between 0.5 and 5 pg/mg and limits of identification between 5 and 50 pg/mg. Mean matrix effect was between -79 and -19% (

Identifiants

pubmed: 35202242
pii: toxics10020055
doi: 10.3390/toxics10020055
pmc: PMC8875502
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Ther Drug Monit. 2020 Apr;42(2):181-193
pubmed: 31425444
J Pediatr. 2019 Feb;205:277-280
pubmed: 30342870
Drug Test Anal. 2019 Sep;11(9):1471-1475
pubmed: 31177632
Drug Test Anal. 2021 Jul;13(7):1371-1382
pubmed: 33750017
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 May 15;867(2):194-204
pubmed: 18424195
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Feb 1;1074-1075:1-7
pubmed: 29329090
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Sep 5;794(2):281-92
pubmed: 12954379
J Pediatr. 2005 Jun;146(6):824-30
pubmed: 15973326
J Anal Toxicol. 2020 Jul 31;44(6):580-588
pubmed: 32064503
Arch Dis Child Fetal Neonatal Ed. 2018 May;103(3):F216-F220
pubmed: 28676561
Addiction. 2010 Dec;105(12):2151-9
pubmed: 20854338
Clin Biochem. 2016 Sep;49(13-14):1096-103
pubmed: 26827634
Clin Pharmacol Ther. 2008 Nov;84(5):604-12
pubmed: 18701886
Anal Bioanal Chem. 2010 Sep;398(2):925-35
pubmed: 20617307
Int J Obstet Anesth. 2020 May;42:34-38
pubmed: 32044215
Drug Test Anal. 2016 Aug;8(8):864-8
pubmed: 26627903
J Chromatogr B Biomed Sci Appl. 1998 Aug 21;713(1):137-46
pubmed: 9700556
Anal Bioanal Chem. 2007 Aug;388(7):1455-65
pubmed: 17370066
J Anal Toxicol. 2007 Jan-Feb;31(1):1-14
pubmed: 17389078
Anal Bioanal Chem. 2014 Dec;406(30):7785-97
pubmed: 25381610
Anal Chem. 2008 Jan 1;80(1):246-52
pubmed: 18044957
Anal Bioanal Chem. 2021 Sep;413(21):5493-5507
pubmed: 34286357
Clin Chim Acta. 2021 Mar;514:40-47
pubmed: 33333045
J Anal Toxicol. 2008 Sep;32(7):485-90
pubmed: 18713516
Ann Clin Lab Sci. 1993 Sep-Oct;23(5):385-94
pubmed: 8239486
J Pharm Biomed Anal. 2019 Aug 5;172:42-49
pubmed: 31022615
Clin Chim Acta. 2006 Apr;366(1-2):101-11
pubmed: 16413011
J Anal Toxicol. 2013 Sep;37(7):452-74
pubmed: 23934984
Ther Drug Monit. 2006 Oct;28(5):700-6
pubmed: 17038890
Arch Pediatr. 1996 May;3(5):440-4
pubmed: 8763713
J Anal Toxicol. 2009 Jun;33(5):243-52
pubmed: 19671243
J Chromatogr A. 2017 May 12;1497:118-126
pubmed: 28372838
Methods Mol Biol. 2016;1383:59-68
pubmed: 26660174
Anal Chem. 2004 Apr 1;76(7):2124-32
pubmed: 15053679
Pediatrics. 1992 Jan;89(1):107-13
pubmed: 1727992

Auteurs

Atakan Hernandez (A)

Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, 264 Rue Saint Pierre, CEDEX 5, 13385 Marseille, France.

Valerie Lacroze (V)

Department of Neonatalogy, La Conception University Hospital, CEDEX 5, 13385 Marseille, France.

Natalia Doudka (N)

Department of Clinical Pharmacology and Pharmacovigilance, La Timone University Hospital, 264 Rue Saint Pierre, CEDEX 5, 13385 Marseille, France.

Jenny Becam (J)

Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, 264 Rue Saint Pierre, CEDEX 5, 13385 Marseille, France.

Carole Pourriere-Fabiani (C)

Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, 264 Rue Saint Pierre, CEDEX 5, 13385 Marseille, France.

Bruno Lacarelle (B)

Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, 264 Rue Saint Pierre, CEDEX 5, 13385 Marseille, France.

Caroline Solas (C)

Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, 264 Rue Saint Pierre, CEDEX 5, 13385 Marseille, France.
Emerging Viruses Unit (UVE), IRD 190, INSERM 1207, Aix-Marseille University, CEDEX 5, 13385 Marseille, France.

Nicolas Fabresse (N)

Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, 264 Rue Saint Pierre, CEDEX 5, 13385 Marseille, France.
Economic and Social Sciences of Health and Medical Information Processing, INSERM, IRD, SESSTIM, Aix-Marseille University, CEDEX 5, 13385 Marseille, France.

Classifications MeSH